All data are available from the fifth Korea National Health and Nutrition Examination Survey. The data can be obtained at the following link: [knhanes.cdc.go.kr](http://knhanes.cdc.go.kr).

Introduction {#sec001}
============

The prevalence of hearing impairment is increasing owing to an aging society and growing use of personal listening devices \[[@pone.0171635.ref001], [@pone.0171635.ref002]\]. Hearing impaired individuals experience decreased hearing ability, reduced dynamic range, lower frequency resolution, reduced temporal resolution, and increased listening fatigue. Hearing impairment can limit their communication and social activity \[[@pone.0171635.ref003]\], leading to a lower quality of life and decreased cognitive function \[[@pone.0171635.ref004]--[@pone.0171635.ref006]\]. The majority of surveys to date have covered only bilateral hearing loss greater than 40 dB HL because of insufficient evidence regarding the effectiveness of interventions. However, individuals with minimal or mild bilateral hearing loss and high frequency hearing loss may experience difficulty understanding speech under adverse listening conditions. Unilateral hearing loss can also predispose individuals to reduced hearing ability and increased listening fatigue.

In an earlier study, Bess et al. (1998) categorized minimal hearing loss (MHL) into three distinct groups (mild bilateral hearing loss, unilateral hearing loss, and high-frequency hearing loss) and demonstrated an association between MHL and educational performance and functional status in school-aged children \[[@pone.0171635.ref007], [@pone.0171635.ref008]\]. Although the definition of MHL differs depending on the source, previous studies have demonstrated that children with MHL are at risk for greater academic, speech-language, and social-emotional difficulties than are their normal hearing peers \[[@pone.0171635.ref007]--[@pone.0171635.ref009]\]. Adults with MHL can also experience less satisfaction and reduced emotional well-being than do normal hearing individuals \[[@pone.0171635.ref009], [@pone.0171635.ref010]\]. Despite this concern, only a few studies have used audiometric testing to gauge the demographic characteristics and associated symptoms of MHL at the national level \[[@pone.0171635.ref011]--[@pone.0171635.ref013]\].

Thus, the objective of this study was to determine the prevalence of MHL in South Korea based on national survey data obtained from the 2010 to 2012 Korea National Health and Nutrition Examination Survey (KNHANES) and assess the quality of life of people with MHL. The definition of MHL used in this study was based on the previous study by Bess et al. (1998).

Methods {#sec002}
=======

Study population and data collection {#sec003}
------------------------------------

This study used the data from the fifth KNHANES. The KNHANES is a nationwide survey conducted annually by the Korea Centers for Disease Control and Prevention to investigate the health and nutritional status of a representative Korean population. Every year, about 10,000 individuals in 3,840 households are selected from a panel to represent the population through a multistage clustered and stratified random sampling method based on the National Census Data. A total of 576 survey areas were drawn from the population and housing census by considering the proportion of each subgroup. The participation rate of selected households was about 80%. From 2010 to 2012, a total of 23,621 individuals (8,313 in 2010, 7,887 in 2011, and 7,421 in 2012) agreed to participate in the health surveys. They underwent ear, nose, and throat (ENT) examinations. To exclude mixed or conductive hearing loss, individuals with tympanic membrane perforation and cholesteatomatous conditions including retraction pocket, otitis media with effusion, and insertion of a ventilation tube were excluded. Among 19,864 participants who had normal tympanic membranes, 16,630 participants completed both the audiometric measurement and the ENT questionnaire.

All participants provided written informed consent before completing the survey. KNHANES followed the tenets of the Declaration of Helsinki for biomedical research. It was approved by the Institutional Review Board of the Korean Centers for Disease Control and Prevention (IRB No. 2010-02CON-21-C, 2011-02CON-06-C, and 2012-01EXP-01-2C). Written informed consent was also obtained from the next of kin, caretakers, or guardians of minors/children enrolled in this survey. Approval for this research study was obtained from the Institutional Review Board of Samsung Medical Center (IRB No. 2016-02-076).

Audiometric measurement and otologic examination {#sec004}
------------------------------------------------

Pure tone threshold was measured in a sound-proof booth using an automatic audiometer (GSI SA-203, Entomed Diagnosics AB, Lena Nodin, Sweden). Otolaryngologists who had been trained to operate the audiometer provided instructions to participants and obtained recordings. Audiometry was performed for participants over 12 years of age. Only air conduction thresholds were measured. Supra-auricular headphones were used in the soundproof booth. The otolaryngologist provided basic instructions to participants regarding the automated hearing test. Automated testing was programmed using a modified Hughson-Westlake procedure with a single pure tone for 1--2 seconds. The lowest pure tone level at which the subject's response rate was 50% was set as the threshold. Participants responded by pushing a button when they heard a tone. Results were automatically recorded. The following frequencies were tested: 0.5, 1, 2, 3, 4, and 6 kHz. An ear examination was conducted with a 4 mm 0°-angled rigid endoscope attached to a Charge-Coupled Device (CCD) camera by trained otolaryngologists. Endoscopic examination was performed to identify tympanic membrane perforation, cholesteatoma (including retraction pocket), and otitis media with effusion (including the presence of a ventilation tube).

Definition of minimal hearing loss {#sec005}
----------------------------------

Minimal sensorineural hearing loss was categorized into three distinct groups according to *Bess et al*. (1998): unilateral sensorineural hearing loss (USHL), bilateral sensorineural hearing loss (BSHL), and high-frequency sensorineural hearing loss (HFSHL) \[[@pone.0171635.ref008]\]. USHL was defined as average air-conduction thresholds (0.5, 1, and 2 kHz) ≥ 15 dB HL in the affected ear and \< 15 dB HL in the unaffected ear. USHL was subdivided into slight hearing loss and mild-to-profound loss. Slight USHL was defined as average air-conduction thresholds \< 25 dB HL. Mild-to-profound USHL was defined as ≥ 25 dB HL. BSHL was defined as average air-conduction thresholds (0.5, 1, and 2 kHz) between 15 and 40 dB HL bilaterally. BSHL was subdivided into minimal BSHL and mild BSHL. Minimal BSHL was defined as average air-conduction thresholds between 15 and 25 dB HL bilaterally. Mild BSHL was defined as average air-conduction thresholds \> 25 dB HL bilaterally. HFSHL was defined as air-conduction thresholds greater than 25 dB HL at two or more frequencies above 2 kHz (i.e., 3, 4, 6 kHz) in one or both ears. Those with HFSHL had normal hearing (\< 15 dB HL) at 0.5, 1, and 2 kHz in both ears. HFSHL was subdivided into unilateral HFSHL and bilateral HFSHL. Normal hearing was defined as average air-conduction thresholds (0.5, 1, and 2 kHz) \< 15 dB HL and less than 25 dB HL in both ears at two or more frequencies above 2 kHz. Moderate hearing loss was defined as average air-conduction thresholds (0.5, 1, and 2 kHz) \> 40 dB HL in either one ear or both ears.

Outcome variables {#sec006}
-----------------

To determine clinical symptoms, participants completed a questionnaire asking about their hearing and whether they had any symptoms of tinnitus. Subjective hearing status was measured by asking the following survey question: "Which sentence best describes your hearing status (while using no HAs)?". There were four answers for the question: (1) "Don't feel difficulty at all," (2) "A little bit difficult," (3) "Very difficult," and (4) "Can't hear at all." Subjective hearing loss was indicated when the response was (2), (3), or (4). Participants were also asked about their experience with tinnitus. In response to the question "Within the past year, did you ever hear a sound (buzzing, hissing, ringing, humming, roaring, machinery noise) originating in your ear?", examiners were instructed to record "yes" if a participant reported that they heard an odd or unusual noise at any time in the past year. Participants who responded positively to this question were then queried concerning the resulting annoyance in their lives using the following questions: "How severe is this noise in daily life?" (not annoying, annoying, severely annoying, or causing sleep problems). Participants were assigned to the group with annoying tinnitus if the severity of tinnitus was annoying or severely annoying. Regarding quality of life, the Euro Qol-5D (EQ-5D) was used to evaluate all participants aged 18 years or older. The EQ-5D is a standard tool used to measure patients' health status in the following five dimensions: mobility, self-care, usual activities, pain/discomfort, and anxiety/depression \[[@pone.0171635.ref014], [@pone.0171635.ref015]\]. Each dimension has three grades of severity: no problem (score of 1), moderate problem (score of 2), or serious problem (score of 3). The EQ-5D index is calculated from the EQ-5D score by applying a formula that assigns weights to each grade in each dimension. This formula differs among nations because it is based on the value of the EQ-5D of the population sample \[[@pone.0171635.ref016]\]. The KNHANES algorithm was used to calculate the EQ-5D index in this study. The EQ-5D index ranged from 1 (best health) to 0 (equivalent to death) or -0.171 (worse than death). To evaluate hearing rehabilitation for MHL, participants were asked about their use of HAs. Responses to the question of "Do you currently use any HAs?" included "yes," "yes, but rarely," "no," and "not applicable." When participants reported having "no difficulty" with their hearing, the use of an HA was considered to be "not applicable."

Statistical analysis {#sec007}
--------------------

All statistical analyses were performed by taking into account the weights from the complex sampling design according to the guidelines for analysis of KNHANES data obtained by the Korea Centers for Disease Control and Prevention. The survey design created a sample weight assigned to each sample individual through the following three steps so that the total sample would represent the population (on average) for the 3-year period (2010--2012): calculating the base weight of the inverse of the final probability of an individual being selected, adjusting for non-response, and post-stratification adjustment to match previous census population control totals. The weights in the 2010, 2011, and 2012 surveys were combined and the average weight (weight for each year/3) was calculated. Statistical analyses were performed using SAS version 9.4 (SAS Institute, Cary, NC, USA). The prevalence of MHL was then estimated. The chi-squared test was used to compare the prevalence of MHL among age groups and according to sex. Logistic regression or linear regression was used to compare the prevalence of MHL to normal hearing according to the responses to the questionnaires. *P*-values were two-sided. Bonferroni's correction was applied to *P*-values and the corresponding confidence intervals owing to multiple testing. Statistical significance was considered when an adjusted *P*-value was less than 0.05.

Results {#sec008}
=======

Prevalence of minimal hearing loss {#sec009}
----------------------------------

Of 16,630 participants, 58.4% had normal hearing, while 37.4% had MHL ([Table 1](#pone.0171635.t001){ref-type="table"}). BSHL accounted for the highest proportion (42.8%) of MHL, followed by USHL (37.5%) and HFSL (19.7%). Among participants with USHL, most participants (80.1% of those with USHL) had slight hearing loss. Among those with HFSHL, both ears were affected in 57.2% of cases, while 42.8% of individuals were affected unilaterally.

10.1371/journal.pone.0171635.t001

###### Prevalence of minimal hearing loss and its subgroups.

![](pone.0171635.t001){#pone.0171635.t001g}

  Classification                Frequency   Weighted Frequency   Weighted Percent (%)
  ----------------------------- ----------- -------------------- ----------------------
  **Normal hearing**            8,511       20,908,897           58.41
  **Minimal hearing loss**      7,058       13,373,850           37.36
   **USHL**                     2,443       5,009,016            13.99
    Slight USHL                 1,949       4,010,785            11.2
    Mild to profound USHL       494         998,231              2.79
   **BSHL**                     3,426       5,724,301            15.99
    Minimal BSHL                1,868       3,323,898            9.29
    Mild BSHL                   1,558       2,400,402            6.71
   **HFSHL**                    1,189       2,640,533            7.38
    Unilateral HFSHL            528         1,130,163            3.16
    Bilateral HFSHL             661         1,510,370            4.22
  **≥ Moderate hearing loss**   1,061       1,513,466            4.23
  **Total**                     16,630      35,796,213           100

USHL, unilateral sensorineural hearing loss; BSHL, bilateral sensorineural hearing loss; HFSHL, high-frequency sensorineural hearing loss

The prevalence of MHL according to nine different age groups is demonstrated in [Fig 1](#pone.0171635.g001){ref-type="fig"}. The prevalence of MHL significantly (*P* \< 0.0001) differed among age groups based on chi-squared testing and post-hoc analysis, except amongst those in their forties (40 to 49 years of age) or fifties (50 to 59 years of age). The prevalence of MHL increased with age until the 6th decade of life (60 to 69 years of age) and decreased afterwards ([Fig 1A](#pone.0171635.g001){ref-type="fig"}). Regarding subcategories of MHL, the prevalence of USHL and HFSHL increased until the 5th decade of life. They then decreased with age. However, the prevalence of BSHL increased with age until the 7th decade of life (70 to 79 years of age) ([Fig 1B](#pone.0171635.g001){ref-type="fig"}).

![Prevalence of minimal hearing loss and its subgroups according to age.\
(A) The prevalence of minimal hearing loss was significantly different between age groups in post-hoc analysis, except among subjects in their forties and fifties. (B) The prevalence of all subgroups of minimal hearing loss were significantly different between age groups in post-hoc analysis. Chi-squared analysis revealed that the prevalence of minimal hearing loss was significantly different between age groups (*P* \< 0.001). An asterisk (\*) indicates a significant difference after adjustment using Bonferroni\'s method. USHL: unilateral sensorineural hearing loss; BSHL: bilateral sensorineural hearing loss; HFSHL: high-frequency sensorineural hearing loss.](pone.0171635.g001){#pone.0171635.g001}

The prevalence of MHL and its subgroups according to sex are shown in [Table 2](#pone.0171635.t002){ref-type="table"}. MHL was predominant in males (41.4%) compared to females (33.3%). HFSHL (unilaterally or bilaterally) was especially prevalent in males (12.2%) ([Table 2](#pone.0171635.t002){ref-type="table"}). When the prevalence of HFSHL was compared among different age groups, HFSHL was also prevalent in males except in those over 70 years old ([Table 3](#pone.0171635.t003){ref-type="table"}).

10.1371/journal.pone.0171635.t002

###### Prevalence of minimal hearing loss and its subgroups according to sex.
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  Sex                           Male    Female       *P*-value                                
  ----------------------------- ------- ------------ ----------- ------- ------------ ------- -------------
  **Normal hearing**            3,310   9798698      54.64       5,201   11110198     62.2    \< 0.0001\*
  **Minimal hearing loss**      3,441   7,427,722    41.42       3,617   5,946,128    33.29   \< 0.0001\*
   **USHL**                     1,059   2,495,340    13.91       1,384   2,513,676    14.07   0.8841
    Slight USHL                 861     2,045,206    11.4        1,088   1,965,579    11      0.4607
    Mild to profound USHL       198     450,134      2.51        296     548,097      3.07    0.1189
   **BSHL**                     1,472   2,740,396    15.28       1,954   2,983,904    16.7    0.0443\*
    Minimal BSHL                792     1,615,053    9.01        1,076   1,708,845    9.57    0.3423
    Mild BSHL                   680     1,125,343    6.28        878     1,275,059    7.14    0.0584
   **HFSHL**                    910     2,191,985    12.22       279     448,548      2.51    \< 0.0001\*
    Unilateral HFSHL            436     984,304      5.49        92      145,859      0.82    \< 0.0001\*
    Bilateral HFSHL             474     1,207,681    6.73        187     302,689      1.69    \< 0.0001\*
  **≥ Moderate hearing loss**   487     706,891      3.94        574     806,575      4.52    
  **Total**                     7,238   17,933,311   100         9,392   17,862,902   100     

The chi-squared test was used to compare the prevalence of minimal hearing loss and its subgroups according to sex. An asterisk (\*) indicates a significant difference (P \< 0.05).

USHL: unilateral sensorineural hearing loss; BSHL: bilateral sensorineural hearing loss; HFSHL: high-frequency sensorineural hearing loss

10.1371/journal.pone.0171635.t003

###### Weighted frequency of minimal hearing loss and its subgroups according to sex and age.
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  Age groups     MHL         adjusted *P*-value   USNHL       adjusted *P*-value   BSHL      adjusted *P*-value   HFSHL     adjusted *P*-value                                   
  -------------- ----------- -------------------- ----------- -------------------- --------- -------------------- --------- -------------------- ----------- --------- --------- -----------
  **12 \~ 19**   177,038     182,998              1.000       112,425              149,661   1.000                43,407    32,379               1.000       21,206    958       \<.0001\*
  **20 \~ 29**   399,892     298,119              0.3672      200,211              230,954   1.000                112,951   58,831               0.835       86,730    8,334     \<.0001\*
  **30 \~ 39**   978,898     567,682              \<.0001\*   414,671              391,691   1.000                220,475   146,791              0.982       343,752   29,200    \<.0001\*
  **40 \~ 49**   1,964,030   1,176,991            \<.0001\*   740,602              629,625   1.000                421,471   405,385              1.000       801,956   141,980   \<.0001\*
  **50 \~ 59**   2,036,032   1,538,692            \<.0001\*   608,902              658,986   1.000                760,143   723,634              1.000       666,987   156,072   \<.0001\*
  **60 \~ 69**   1,195,088   1,179,316            \<.0001\*   302,672              306,327   1.000                675,283   793,970              0.449       217,133   79,019    \<.0001\*
  **70 \~ 79**   603,489     882,917              \<.0001\*   110,878              142,028   1.000                441,461   707,906              \<.0001\*   51,149    32,984    1.000
  **80\~**       72,993      114,174              0.4192      4,978                4,403     1.000                64,942    109,771              0.744       \-        \-        \-

The chi-squared test was used to compare the prevalence of minimal hearing loss and its subgroups according to sex and age. An asterisk (\*) indicates a significant difference (adjusted P \< 0.05).

MHL: Minimal sensorineural hearing loss; USHL: unilateral sensorineural hearing loss; BSHL: bilateral sensorineural hearing loss; HFSHL: high-frequency sensorineural hearing loss

Normal hearing versus minimal hearing loss {#sec010}
------------------------------------------

After excluding participants who had worse than moderate hearing loss (PTA \> 40 dB HL either in one ear or both ears), a total of 15,569 participants were analyzed to compare the prevalence of MHL to that of normal hearing using linear and logistic regression analyses. In univariate analyses, the prevalence of MHL increased with age (*P* \< 0.0001, OR: 1.098, 95% CI: 1.093--1.102). It was higher in males (*P* \< 0.0001, OR: 1.416, 95% CI: 1.307--1.534) ([Table 4](#pone.0171635.t004){ref-type="table"}). The prevalence of the subgroups of MHL also increased with age, especially for BSHL (*P* \< 0.0001, OR: 1.135, 95% CI: 1.124--1.146). However, sex was associated with the prevalence of MHL only for HFSHL. HFSHL was significantly predominant in males (*P* \< 0.0001, OR: 5.541, 95% CI: 4.478--6.857). The prevalence of MHL in the HFSHL subgroup was also higher in males, regardless of whether the ear was affected unilaterally (*P* \< 0.0001, OR: 7.651, 95% CI: 5.138--11.392) or bilaterally (*P* \< 0.0001, OR: 4.524, 95% CI: 3.396--6.027).

10.1371/journal.pone.0171635.t004

###### Univariate analyses of age and sex in the minimal hearing loss group compared to the normal hearing group.
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  ----------------------------- --------------- ------------------------ -------------------------- --------------- -------- ---------------
  **Age**                       **Frequency**   **Weighted Frequency**   **Average (years)**        ***P*-value**   **OR**   **95% CI**
  **Classifications**                                                                                                        
  **Total**                     15,569          34,282,747               35.16                      \-              \-       \-
  **Normal hearing (ref)**      8,511           20,908,897               32.52                      ref             ref      ref
  **Minimal hearing loss**      7,058           13,373,850               51.62                      \< 0.0001\*     1.098    1.093--1.102
   **USHL**                     2,443           5,009,016                46.19                      \< 0.0001\*     1.074    1.067--1.082
    Slight USHL                 1,949           4,010,785                46.67                      \< 0.0001\*     1.078    1.070--1.087
    Mild to profound USHL       494             998,231                  44.24                      \< 0.0001\*     1.064    1.046--1.082
   **BSHL**                     3,426           5,724,301                57.91                      \< 0.0001\*     1.135    1.124--1.146
    Minimal BSHL                1,868           3,323,898                54.36                      \< 0.0001\*     1.120    1.109--1.131
    Mild BSHL                   1,558           2,400,402                62.81                      \< 0.0001\*     1.180    1.158--1.203
   **HFSHL**                    1,189           2,640,533                48.3                       \< 0.0001\*     1.096    1.089--1.104
    Unilateral HFSHL            528             1,130,163                51.19                      \< 0.0001\*     1.114    1.102--1.126
    Bilateral HFSHL             661             1,510,370                46.14                      \< 0.0001\*     1.08     1.071--1.090
  **Sex**                       **Frequency**   **Weighted Frequency**   **Weighted Percent (%)**   ***P*-value**   **OR**   **95% CI**
  **Classifications**                                                                                                        
  **Total**                                                                                                                  
  male                          6,751           17,226,420               50.25                      \-              \-       \-
  female                        8,818           17,056,327               49.75                                               
  **Normal hearing (ref)**                                                                                                   
  male                          3,310           9,798,698                46.86                      ref             ref      ref
  female                        5,201           11,110,198               53.14                                               
  **Minimal hearing loss**                                                                                                   
  male (ref)                    3,441           7,427,722                55.54                      \< 0.0001\*     1.416    1.307--1.534
  female                        3,617           5,946,128                44.46                                               
   **USHL**                                                                                                                  
  male (ref)                    1,059           2,495,340                49.82                      0.1479          1.126    0.975--1.299
  female                        1,384           2,513,676                50.18                                               
    **Slight USHL**                                                                                                          
  male (ref)                    861             2,045,206                50.99                      0.0516          1.18     1.000--1.392
  female                        1,088           1,965,579                49.01                                               
    **Mild to profound USHL**                                                                                                
  male (ref)                    198             450,134                  45.09                      1.000           0.931    0.659--1.316
  female                        296             548,097                  54.91                                               
   **BSHL**                                                                                                                  
  male (ref)                    1,472           2,740,396                47.87                      1.000           1.041    0.923--1.175
  female                        1,954           2,983,904                52.13                                               
    **Minimal BSHL**                                                                                                         
  male (ref)                    792             1,615,053                9.01                       1.000           1.072    0.900--1.276
  female                        1,076           1,708,845                9.57                                                
    **Mild BSHL**                                                                                                            
  male (ref)                    680             1,125,343                6.28                       1.000           1.001    0.831--1.206
  female                        878             1,275,059                7.14                                                
   **HFSHL**                                                                                                                 
  male (ref)                    910             2,191,985                83.01                      \< 0.0001\*     5.541    4.478--6.857
  female                        279             448,548                  16.99                                               
    **Unilateral HFSHL**                                                                                                     
  male (ref)                    436             984,304                  87.09                      \< 0.0001\*     7.651    5.138--11.392
  female                        92              145,859                  12.91                                               
    **Bilateral HFSHL**                                                                                                      
  male (ref)                    474             1,207,681                79.96                      \< 0.0001\*     4.524    3.396--6.027
  female                        187             302,689                  20.04                                               
  ----------------------------- --------------- ------------------------ -------------------------- --------------- -------- ---------------

An asterisk (\*) indicates a significant difference (P \< 0.05).

USHL, unilateral sensorineural hearing loss; BSHL, bilateral sensorineural hearing loss; HFSHL, high-frequency sensorineural hearing loss; CI, confidence interval; OR, odds ratio

Comparisons of participants with MHL and normal hearing regarding subjective complaints of hearing loss and tinnitus are summarized in [Table 5](#pone.0171635.t005){ref-type="table"}. Compared to normal hearing participants, the proportion of participants complaining about their hearing difficulties was significantly higher in participants with MHL (*P* \< 0.0001, OR: 2.729, 95% CI 2.217--3.360) after adjusting for age and sex. While 13.0% of participants with MHL reported difficulties with their hearing, only 3.1% of participants with normal hearing reported subjective hearing loss. In multivariate analyses, participants with MHL also complained of tinnitus significantly more than did normal hearing participants (*P* \< 0.0001, OR: 1.520, 95% CI: 1.333--1.734). Annoying tinnitus was observed significantly more often in participants with MHL compared to those with normal hearing (*P* \< 0.0001, OR: 1.868, 95% CI: 1.511--2.310). In the subgroups, participants with mild-to-profound USHL complained of their hearing difficulties the most (*P* \< 0.0001, OR: 6.556, 95% CI: 3.904--11.010), followed by participants with mild BSHL (*P* \< 0.0001, OR: 6.352, 95% CI: 4.229--9.540). Regarding tinnitus, participants with mild BSHL mostly reported tinnitus (*P* \< 0.0001, OR: 3.145, 95% CI: 2.362--4.189), while participants with mild-to-profound USHL mostly reported annoying tinnitus (*P* \< 0.0001, OR: 3.906, 95% CI: 2.277--6.701).

10.1371/journal.pone.0171635.t005

###### Univariate and multivariate analyses of clinical symptoms in the minimal hearing loss group compared to the normal hearing group.
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  ----------------------------------- --------------- ------------------------ -------------------------- -------------------------- ---------------------------- -------------- ------------- ------- ---------------
  **Classifications**                 **Frequency**   **Weighted Frequency**   **Weighted Percent (%)**   **Univariable analysis**   **Multivariable analysis**                                        
  ***P*-value**                       **OR**          **95% CI**               ***P*-value**              **OR**                     **95% CI**                                                        
  **Subjective hearing loss**                                                                                                                                                                          
  **Total**                                                                                                                                                                                            
  not discomfort                      14,245          31,889,494               93                         \-                         \-                           \-             \-            \-      \-
  discomfort                          1,324           2,393,253                7                                                                                                                       
  **Normal hearing (ref)**                                                                                                                                                                             
  not discomfort                      8,243           20,255,980               96.9                       ref                        ref                          ref            ref           ref     ref
  discomfort                          268             652,917                  3.1                                                                                                                     
  **Minimal hearing loss**                                                                                                                                                                             
  not discomfort                      6,002           11,633,514               87                         \< 0.0001\*                4.641                        3.901--5.522   \< 0.0001\*   2.729   2.217--3.360
  discomfort (event)                  1,056           1,740,336                13                                                                                                                      
   **USHL**                                                                                                                                                                                            
  not discomfort                      2,178           4,515,893                90.2                       \< 0.0001\*                3.388                        1.599--2.119   \< 0.0001\*   2.484   1.815--3.400
  discomfort (event)                  265             493,123                  9.8                                                                                                                     
    **Slight USHL**                                                                                                                                                                                    
  not discomfort                      1,796           3,729,636                93                         \< 0.0001\*                2.339                        1.258--1.859   0.0168\*      1.61    1.059--2.447
  discomfort (event)                  153             281,149                  7                                                                                                                       
    **Mild to profound USHL**                                                                                                                                                                          
  not discomfort                      382             786,257                  78.8                       \< 0.0001\*                8.365                        2.266--3.692   \< 0.0001\*   6.556   3.904--11.010
  discomfort (event)                  112             211,974                  21.2                                                                                                                    
   **BSHL**                                                                                                                                                                                            
  not discomfort                      2,738           4,672,983                81.6                       \< 0.0001\*                6.98                         2.360--2.957   \< 0.0001\*   3.781   2.768--5.166
  discomfort (event)                  688             1,051,318                18.4                                                                                                                    
    **Minimal BSHL**                                                                                                                                                                                   
  not discomfort                      1,625           2,923,129                87.9                       \< 0.0001\*                4.254                        1.782--2.388   \< 0.0001\*   2.687   1.782--4.051
  discomfort (event)                  243             400,770                  12.1                                                                                                                    
    **Mild BSHL**                                                                                                                                                                                      
  not discomfort                      1,113           1,749,854                72.9                       \< 0.0001\*                11.534                       2.957--3.901   \< 0.0001\*   6.352   4.229--9.540
  discomfort (event)                  445             650,548                  27.1                                                                                                                    
   **HFSHL**                                                                                                                                                                                           
  not discomfort                      1,086           2,444,638                92.6                       \< 0.0001\*                2.486                        1.316--1.889   0.0141\*      1.732   1.090--2.752
  discomfort (event)                  103             195,895                  7.4                                                                                                                     
    **Unilateral HFSHL**                                                                                                                                                                               
  not discomfort                      466             1,004,601                88.9                       \< 0.0001\*                3.878                        1.529--2.537   \< 0.0001\*   2.499   1.351--4.622
  discomfort (event)                  62              125,562                  11.1                                                                                                                    
    **Bilateral HFSHL**                                                                                                                                                                                
  not discomfort                      620             1,440,037                95.3                       0.3012                     1.515                        0.931--1.628   1.000         1.089   0.563--2.108
  discomfort (event)                  41              70,333                   4.7                                                                                                                     
  **Presence of tinnitus**                                                                                                                                                                             
  **Total**                                                                                                                                                                                            
  yes                                 3,120           6,679,347                19.5                       \-                         \-                           \-             \-            \-      \-
  no                                  12,449          27,603,399               80.5                                                                                                                    
  **Normal hearing (ref)**                                                                                                                                                                             
  yes                                 1,435           3,616,316                17.3                       ref                        ref                          ref            ref           ref     ref
  no                                  7,076           17,292,580               82.7                                                                                                                    
  **Minimal hearing loss**                                                                                                                                                                             
  yes (event)                         1,685           3,063,031                22.9                       \< 0.0001\*                1.421                        1.275--1.583   \< 0.0001\*   1.520   1.333--1.734
  no                                  5,373           10,310,819               77.1                                                                                                                    
   **USHL**                                                                                                                                                                                            
  yes (event)                         527             1,065,106                21.3                       0.0018\*                   1.291                        1.040--1.242   \< 0.0001\*   1.460   1.199--1.776
  no                                  1,916           3,943,910                78.7                                                                                                                    
    **Slight USHL**                                                                                                                                                                                    
  yes (event)                         393             798,167                  19.9                       0.2598                     1.188                        0.974--1.219   0.0042\*      1.376   1.075--1.762
  no                                  1,556           3,212,618                80.1                                                                                                                    
    **Mild to profound USHL**                                                                                                                                                                          
  yes (event)                         134             266,939                  26.7                       0.0002\*                   1.745                        1.108--1.575   \< 0.0001\*   2.010   1.388--2.912
  no                                  360             731,292                  73.3                                                                                                                    
   **BSHL**                                                                                                                                                                                            
  yes (event)                         906             1,462,309                25.5                       \< 0.0001\*                1.641                        1.184--1.386   \< 0.0001\*   1.939   1.580--2.378
  no                                  2,520           4,261,991                74.5                                                                                                                    
    **Minimal BSHL**                                                                                                                                                                                   
  yes (event)                         490             756,671                  31.5                       0.0216\*                   1.289                        1.012--1.273   \< 0.0001\*   1.637   1.260--2.126
  no                                  1,068           1,643,731                68.5                                                                                                                    
    **Mild BSHL**                                                                                                                                                                                      
  yes (event)                         252             535,615                  20.3                       \< 0.0001\*                2.201                        1.343--1.639   \< 0.0001\*   3.145   2.362--4.189
  no                                  937             2,104,918                79.7                                                                                                                    
   **HFSHL**                                                                                                                                                                                           
  yes (event)                         252             535,615                  20.3                       0.1653                     1.217                        0.976--1.246   \< 0.0001\*   1.871   1.402--2.496
  no                                  937             2,104,918                79.7                                                                                                                    
    **Unilateral HFSHL**                                                                                                                                                                               
  yes (event)                         115             227,892                  20.2                       1                          1.208                        0.914--1.322   \< 0.0001\*   2.006   1.315--3.060
  no                                  413             902,271                  79.8                                                                                                                    
    **Bilateral HFSHL**                                                                                                                                                                                
  yes (event)                         137             307,723                  20.4                       0.7446                     1.224                        0.931--1.315   0.0004\*      1.784   1.224--2.600
  no                                  524             1,202,647                79.6                                                                                                                    
  **Presence of annoying tinnitus**                                                                                                                                                                    
  **Total**                                                                                                                                                                                            
  yes                                 14,688          32,548,170               94.9                       \-                         \-                           \-             \-            \-      \-
  no                                  881             1,734,576                5.1                                                                                                                     
  **Normal hearing (ref)**                                                                                                                                                                             
  yes                                 8,225           20,231,329               96.8                       ref                        ref                          ref            ref           ref     ref
  no                                  286             677,568                  3.2                                                                                                                     
  **Minimal hearing loss**                                                                                                                                                                             
  yes (event)                         6,463           12,316,841               92.1                       \< 0.0001\*                2.562                        2.129--3.083   \< 0.0001\*   1.868   1.511--2.310
  no                                  595             1,057,008                7.9                                                                                                                     
   **USHL**                                                                                                                                                                                            
  yes (event)                         2,266           4,650,684                92.8                       \< 0.0001\*                2.301                        1.308--1.759   \< 0.0001\*   1.946   1.413--2.680
  no                                  177             358,332                  7.2                                                                                                                     
    **Slight USHL**                                                                                                                                                                                    
  yes (event)                         1,833           3,781,937                94.3                       0.0002\*                   1.807                        1.117--1.618   0.0186\*      1.545   1.050--2.274
  no                                  116             228,848                  5.7                                                                                                                     
    **Mild to profound USHL**                                                                                                                                                                          
  yes (event)                         433             868,748                  87                         \< 0.0001\*                4.45                         1.626--2.736   \< 0.0001\*   3.906   2.277--6.701
  no                                  61              129,484                  13                                                                                                                      
   **BSHL**                                                                                                                                                                                            
  yes (event)                         3,080           5,174,162                90.4                       \< 0.0001\*                3.175                        1.568--2.025   \< 0.0001\*   2.099   1.5523--2.894
  no                                  346             550,139                  9.6                                                                                                                     
    **Minimal BSHL**                                                                                                                                                                                   
  yes (event)                         1,735           3,103,064                93.4                       \< 0.0001\*                2.125                        1.205--1.764   0.0210\*      1.589   1.048--2.410
  no                                  133             220,834                  6.6                                                                                                                     
    **Mild BSHL**                                                                                                                                                                                      
  yes (event)                         1,345           2,071,097                86.3                       \< 0.0001\*                4.748                        1.869--2.541   \< 0.0001\*   3.618   2.213--5.915
  no                                  213             329,305                  13.7                                                                                                                    
   **HFSHL**                                                                                                                                                                                           
  yes (event)                         1,117           2,491,995                94.4                       0.0018\*                   1.78                         1.093--1.629   0.00451\*     1.952   1.183--3.2219
  no                                  72              148,538                  5.6                                                                                                                     
    **Unilateral HFSHL**                                                                                                                                                                               
  yes (event)                         491             1,069,736                94.7                       0.0774                     1.687                        0.985--1.712   0.162         1.734   0.901--3.336
  no                                  37              60,427                   5.3                                                                                                                     
    **Bilateral HFSHL**                                                                                                                                                                                
  yes (event)                         626             1,422,260                94.2                       0.0324\*                   1.85                         1.018--1.818   0.0288\*      2.032   1.049--3.935
  no                                  35              88,111                   5.8                                                                                                                     
  **Classifications**                 **Frequency**   **Weighted Frequency**   **Average**                **Univariable analysis**   **Multivariable analysis**                                        
  ***P*-value**                       ***P*-value**                                                                                                                                                    
  **EQ-5D index**                                                                                                                                                                                      
  **Total**                           13,730          29,912,914               0.956                      \-                         \-                                                                
  **Normal hearing (ref)**            6,906           17,066,487               0.972                      ref                        ref                                                               
  **Minimal hearing loss**            6,824           12,846,427               0.935                      \< 0.0001\*                \< 0.0001\*                                                       
   **USHL**                           2,311           4,716,951                0.949                      \< 0.0001\*                0.0024\*                                                          
    Slight USHL                       1,850           3,785,067                0.949                      \< 0.0001\*                0.0078\*                                                          
    Mild to profound USHL             461             931,884                  0.95                       0.0001\*                   1.000                                                             
   **BSHL**                           3,348           5,558,945                0.911                      \< 0.0001\*                \< 0.0001\*                                                       
    Minimal BSHL                      1,868           3,323,898                0.926                      \< 0.0001\*                \< 0.0001\*                                                       
    Mild BSHL                         1558            2,400,402                0.889                      \< 0.0001\*                \< 0.0001\*                                                       
   **HFSHL**                          1,165           2,570,532                0.962                      0.0084\*                   0.936                                                             
    Unilateral HFSHL                  520             1,099,964                0.961                      0.168                      1.000                                                             
    Bilateral HFSHL                   645             1,470,568                0.962                      0.1752                     1.000                                                             
  ----------------------------------- --------------- ------------------------ -------------------------- -------------------------- ---------------------------- -------------- ------------- ------- ---------------

Multivariate analysis adjusted for age and sex. An asterisk (\*) indicates a significant difference (P \< 0.05).

USHL, unilateral sensorineural hearing loss; BSHL, bilateral sensorineural hearing loss; HFSHL, high-frequency sensorineural hearing loss; CI, confidence interval; OR, odds ratio

A total of 13,730 participants completed the EQ-5D survey. Compared to the normal hearing group, the MHL group had a significantly (*P* \< 0.0001) lower mean EQ-5D index score in the linear regression analysis after adjusting for age and sex. The average EQ-5D indices in the normal hearing and MHL groups were 0.972 and 0.935, respectively. In the subgroups, the mild BSHL group had the lowest average score on the EQ-5D (0.889), followed by the minimal BSHL group (0.926).

Hearing rehabilitation in minimal hearing loss {#sec011}
----------------------------------------------

The use of HAs among those with MHL is shown in [Table 6](#pone.0171635.t006){ref-type="table"}. Among participants who suffered from subjective hearing loss, only 0.47% of minimally hearing impaired participants used HAs. Especially in the USHL and HFHL groups, hearing aids were hardly ever used. Among participants who reported subjective hearing loss, the percentage of hearing aid users did not differ significantly between participants with MHL and those with normal hearing (*P* = 0.2703, OR: 0.269, 95% CI: 0.026--2.785) in logistic regression analysis after adjusting for age and sex.

10.1371/journal.pone.0171635.t006

###### The use of hearing aids by participants with minimal hearing loss.

![](pone.0171635.t006){#pone.0171635.t006g}

  Classification             Total    Subjective hearing   Use of hearing aids   Weighted percent (%)\*               
  -------------------------- -------- -------------------- --------------------- ------------------------ --- ------- ------
  **Total**                  15,569   14,243               1,324                 7                        2   1,317   0.40
  **Normal hearing (ref)**   8,511    8,243                268                   1                        0   267     0.21
  **Minimal hearing loss**   7,058    6,002                1,056                 6                        2   1,048   0.47
   **USHL**                  2,443    2,178                265                   0                        0   265     0.00
    Slight USHL              1,949    1,796                153                   0                        0   153     0.00
    Mild to profound USHL    494      382                  112                   0                        0   112     0.00
   **BSHL**                  3,426    2,738                688                   5                        2   681     0.66
    Minimal BSHL             1,868    1,625                243                   1                        0   242     0.16
    Mild BSHL                1,558    1,113                445                   4                        2   441     0.97
   **HFSHL**                 1,189    1,086                103                   1                        0   102     0.58
    Unilateral HFSHL         528      466                  62                    1                        0   61      0.90
    Bilateral HFSHL          661      620                  41                    0                        0   41      0.00

A questionnaire on the use of hearing aids was given to participants with subjective hearing loss. Weighted percent (%)\* = number of current hearing aid users/number of participants with subjective hearing loss. USHL, unilateral sensorineural hearing loss; BSHL, bilateral sensorineural hearing loss; HFSHL, high-frequency sensorineural hearing loss; CI, confidence interval; OR, odds ratio

Discussion {#sec012}
==========

Using data from the KNHANES 2010--2012, we found that the weighted prevalence of MHL in the South Korean population aged 12 years or older was 37.4%. When MHL was divided into subgroups (USHL, BSHL, and HFSHL), the prevalence of USHL, BSHL, and HFSHL were 14%, 16%, and 7.4%, respectively. These prevalence rates are similar to those found in a previous survey, although there might be some differences in the definitions of hearing loss. The WHO prevalence statistics from 2012 were based on a definition of mild hearing loss as an average threshold at 0.5, 1, 2, and 4 kHz of between 26 and 40 dB HL \[[@pone.0171635.ref011]\]. The BSHL for all adults aged 15 years or older was calculated to be 9% to 17%, depending on geographic region. Based on the data from the US NHANES (2001--2008) study, USHL was defined as an average threshold at 0.5, 1, 2, and 4 kHz of greater than 25 dB HL in one ear \[[@pone.0171635.ref017]\]. The prevalence of USHL was reported to be 7.6% for participants aged 12 years or older \[[@pone.0171635.ref017]\].

In the present study, BSHL was the most prevalent category (48.5%), followed by USHL (34.6%) and HFSL (16.8%). Compared to a population-based study on Canadian children aged 0 to 18 years, the prevalence of each subgroup was slightly different. Although BSHL was the most prevalent category in both studies, USHL was more prevalent in adults aged 12 years or older than in children aged 18 years or younger (BSHL: 70%, bilateral HFSHL: 11.6%, and USHL: 18.4% in the Canadian study) \[[@pone.0171635.ref018]\]. This might be due to acquired unilateral hearing loss, such as sudden sensorineural hearing loss. The prevalence of MHL increased with age until participants were in their sixties. However, it decreased in those in their sixties to eighties ([Fig 1A](#pone.0171635.g001){ref-type="fig"}). The prevalence of USHL and HFSHL decreased with age after participants reached their fifties ([Fig 1B](#pone.0171635.g001){ref-type="fig"}). It is well known that the prevalence of hearing loss can rise sharply in adults over age 50 \[[@pone.0171635.ref012]\]. For that reason, subjects with HFSHL and USHL could be categorized into the moderate hearing loss group over time, especially after their fifties. Regarding sex, HFSHL was significantly more prevalent in males ([Table 2](#pone.0171635.t002){ref-type="table"}), which is consistent with previous results \[[@pone.0171635.ref001], [@pone.0171635.ref002], [@pone.0171635.ref013]\].

The present study found that the proportion of participants complaining about their hearing with MHL was significantly higher than the proportion of normal hearing participants complaining about their hearing in univariate and multivariate analyses ([Table 5](#pone.0171635.t005){ref-type="table"}). Participants with mild-to-profound USHL and mild BSHL complained of their hearing with a high odds ratio (OR: 6.556 for mild-to-profound USHL and 6.352 for mild BSHL, [Table 5](#pone.0171635.t005){ref-type="table"}) compared to the normal hearing group after adjustment for age and sex. The minimally impaired hearing group also complained of annoying tinnitus significantly more than did the normal hearing group, especially participants with mild BSHL and mild-to-profound USHL (OR: 3.906 for mild-to-profound USHL and 3.618 for mild BSHL, [Table 5](#pone.0171635.t005){ref-type="table"}). These observations emphasize the need to provide appropriate counseling to patients with MHL and to encourage them to consider communication strategies, assistive listening devices, or HAs. The use of assistive listening devices or HAs in patients with MHL may improve their communication by reducing the effort required for them to listen, particularly in noisy environments. Besides, HAs have been known to be effective for tinnitus-associated MHL by masking or distracting from tinnitus with amplified environmental sound \[[@pone.0171635.ref019], [@pone.0171635.ref020]\].

Despite suffering from subjective hearing loss, only 0.47% of participants with MHL reported that they currently use HAs ([Table 6](#pone.0171635.t006){ref-type="table"}). A previous study reported that a total of 12.6% of subjects who had bilateral moderate-to-profound hearing loss (\> 40dB hearing threshold measured at 0.5, 1, 2, and 3 kHz) and subjective hearing loss regularly used HAs \[[@pone.0171635.ref021]\]. Compared to those with bilateral moderate-to-profound hearing loss, participants with MHL rarely used HAs. Auditory rehabilitation has been directed toward remediating the disabilities or handicaps experienced by individuals who have hearing impairments at a hearing level greater than 30 to 40 dB \[[@pone.0171635.ref022]\]. There are some limitations to treating MHL, including cost, lack of insurance coverage, social stigma, and lack of engagement by health care providers. A number of consumer studies have suggested that, among an array of limitations, one factor responsible for the lower adoption of HAs by those with mild hearing loss might be clinicians themselves. The MarkeTrak survey in 2012 suggested that 29% of individuals who report mild hearing loss have discussed their hearing problems with an audiologist, 43% are advised to wait and retest, and 26% are told that HAs would not be beneficial \[[@pone.0171635.ref023]\]. One reason for advising against HAs may be that HAs are deemed less beneficial for those with mild hearing loss. Among patients with MHL for whom cost is a primary concern, personal sound amplification products (PSAP) could be a solution. According to a recently published article, a PSAP is a one-size fits all electronic device that can amplify soft sounds \[[@pone.0171635.ref024]\]. These devices were originally designed for normal hearing users to heighten their hearing ability for recreational activities. They can often be purchased at a low cost. Even though these products are not medically approved or recommended as a treatment option for permanent hearing loss, a PSAP can be a helpful, affordable, and accessible initial option for those with bilateral MHL. Regarding mild-to-profound USHL, bone conduction devices, contralateral routing of sound systems, and cochlear implants could be options for auditory rehabilitation. Although previous studies have shown a lack of beneficial effect of bone conduction devices or contralateral routing of sound systems regarding sound localization, speech perception is improved with these devices when speech is presented to the poorer ear \[[@pone.0171635.ref025], [@pone.0171635.ref026]\]. Single-sided deafness is now being considered as an indication for cochlear implantation and many studies have reported the benefits of cochlear implantation regarding sound localization, speech perception in noisy environments, and tinnitus \[[@pone.0171635.ref027], [@pone.0171635.ref028]\].

In conclusion, MHL is common in South Korea. It is associated with significant hearing problems, including subjective hearing discomfort, tinnitus, and poor quality of life. Nevertheless, hearing rehabilitation is extremely limited for patients with MHL. Therefore, minimally hearing-impaired patients, especially those with hearing handicaps, might be considered as candidates for auditory rehabilitation, including counselling regarding communication strategies and the option to evaluate the potential benefits of sound amplification.
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